Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Zhang, Xiao-Hui  [Clear All Filters]
2016
Xu L-P, Xu Z-L, Zhang X-H, Chen H, Chen Y-H, Han W, Chen Y, Wang F-R, Wang J-Z, Wang Y, et al. Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia. Biol Blood Marrow Transplant. 2016.
Shi M-M, Kong Y, Song Y, Sun Y-Q, Wang Y, Zhang X-H, Xu L-P, Liu K-Y, Huang X-J. Atorvastatin enhances endothelial cell function in post transplant poor graft function. Blood. 2016.
Guo Z-P, Wang T, Xu L-P, Zhang X-H, Wang Y, Huang X-J, Chang Y-J. Factors affecting the CD34(+) cell yields from the second donations of healthy donors: The steady-state lymphocyte count is a good predictive factor. Transfus Apher Sci. 2016.
Zhang X-H, Feng F-E, Han W, Wang F-R, Wang J-Z, Wang Y, Chen Y, Fu H-X, Mo X-D, Zhang Y-Y, et al. High-dose corticosteroid associated with catheter-related thrombosis after allogeneic hematopoietic stem cell transplantation. Thromb Res. 2016;144:6-11.
Kong Y, Song Y, Hu Y, Shi M-M, Wang Y-T, Wang Y, Zhang X-H, Xu L-P, Liu K-Y, Deng H-K, et al. Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants. Oncotarget. 2016.
Wang Y-T, Kong Y, Song Y, Han W, Zhang Y-Y, Zhang X-H, Chang Y-J, Jiang Z-F, Huang X-J. Increased type 1 immune response in the bone marrow immune microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2016.
Tian D-M, Wang Y, Zhang X-H, Liu K-Y, Huang X-J, Chang Y-J. Rapid Recovery of CD3+CD8+ T Cells on Day 90 Predicts Superior Survival after Unmanipulated Haploidentical Blood and Marrow Transplantation. PLoS One. 2016;11(6):e0156777.
Mo X-D, Zhang X-H, Xu L-P, Wang Y, Yan C-H, Chen H, Chen Y-H, Han W, Wang F-R, Wang J-Z, et al. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation in First Complete Remission Can Abrogate the Poor Outcomes of Children with Acute Myeloid Leukemia Resistant to the First Course of Induction Chemotherapy. Biol Blood Marrow Transplant. 2016.

Pages